These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16146185)

  • 21. Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs.
    Ramasubbu R; Ravindran A; Lapierre Y
    Pharmacopsychiatry; 2000 Nov; 33(6):236-8. PubMed ID: 11147933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].
    Scholl HP; Kasper S; Danos P; Höflich G; Möller HJ
    Nervenarzt; 1994 Jul; 65(7):478-81. PubMed ID: 7800092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.
    Bogetto F; Bellino S; Vaschetto P; Ziero S
    Psychiatry Res; 2000 Oct; 96(2):91-8. PubMed ID: 11063782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risperidone-induced obsessive-compulsive symptoms: a series of six cases.
    Alevizos B; Lykouras L; Zervas IM; Christodoulou GN
    J Clin Psychopharmacol; 2002 Oct; 22(5):461-7. PubMed ID: 12352268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obsessive-compulsive symptoms in schizophrenia induced by risperidone and responding to fluoxetine.
    Levy E; Margolese HC; Sultan S; Chouinard G
    Can J Psychiatry; 2003 Nov; 48(10):709-10. PubMed ID: 14674056
    [No Abstract]   [Full Text] [Related]  

  • 26. Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia.
    Yasui-Furukori N; Kondo T; Mihara K; Inoue Y; Kaneko S
    Psychopharmacology (Berl); 2004 Jan; 171(2):223-7. PubMed ID: 12955290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obsessive-compulsive disorder (OCD) with psychotic symptoms and response to treatment with SSRI.
    Sievers M; Sato T; Möller HJ; Bottlender R
    Pharmacopsychiatry; 2005 Mar; 38(2):104-5. PubMed ID: 15744638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophrenia.
    Miyamoto S; Miyake N; Ogino S; Endo T; Yamaguchi N
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):702-3. PubMed ID: 18081639
    [No Abstract]   [Full Text] [Related]  

  • 29. Obsessive-compulsive disorder with non-24-hour sleep-wake syndrome.
    Morinobu S; Yamashita H; Yamawaki S; Tanaka K; Ohkawa M
    J Clin Psychiatry; 2002 Sep; 63(9):838-40. PubMed ID: 12363127
    [No Abstract]   [Full Text] [Related]  

  • 30. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive treatment of three patients with comorbid OCPD and ADHD.
    Josephson SC; Hollander E; Sumner J
    CNS Spectr; 2007 May; 12(5):338-42. PubMed ID: 17514078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractory obsessive-compulsive disorder: state-of-the-art treatment.
    Hollander E; Bienstock CA; Koran LM; Pallanti S; Marazziti D; Rasmussen SA; Ravizza L; Benkelfat C; Saxena S; Greenberg BD; Sasson Y; Zohar J
    J Clin Psychiatry; 2002; 63 Suppl 6():20-9. PubMed ID: 12027116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obsessive-compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature.
    Ke CL; Yen CF; Chen CC; Yang SJ; Chung W; Yang MJ
    Kaohsiung J Med Sci; 2004 Jun; 20(6):295-301. PubMed ID: 15253471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tic syndrome].
    Czapliński A; Steck AJ; Fuhr P
    Neurol Neurochir Pol; 2002; 36(3):493-504. PubMed ID: 12185806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of sumatriptan in the treatment of obsessive-compulsive disorder in an adolescent.
    Pathak S; Cottingham EM; McConville BJ
    J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S93-4. PubMed ID: 12880505
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcome of additional behaviour therapy including treatment discontinuation for fluvoxamine non-responders with obsessive-compulsive disorder.
    Nakatani E; Nakagawa A
    Psychother Psychosom; 2008; 77(6):393-4. PubMed ID: 18716426
    [No Abstract]   [Full Text] [Related]  

  • 37. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
    Weiss EL; Potenza MN; McDougle CJ; Epperson CN
    J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms.
    Rodriguez CI; Corcoran C; Simpson HB
    Am J Psychiatry; 2010 Jul; 167(7):754-61. PubMed ID: 20595428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obsessive-compulsive symptoms with risperidone.
    Mahendran R
    J Clin Psychiatry; 1999 Apr; 60(4):261-3. PubMed ID: 10221290
    [No Abstract]   [Full Text] [Related]  

  • 40. Tiagabine augmentation to fluvoxamine-risperidone combination in the treatment of obsessive-compulsive disorder.
    Oulis P; Masdrakis VG; Karapoulios E; Karakatsanis NA; Kouzoupis AV; Konstantakopoulos G; Soldatos CR
    World J Biol Psychiatry; 2009; 10(4 Pt 3):953-5. PubMed ID: 19224410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.